Menin Inhibition With Revumenib for <i>KMT2A</i>-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M.

Afiliação

Issa GC; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Aldoss I; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
Thirman MJ; Biological Sciences Division, The University of Chicago Medicine, Chicago, IL.
DiPersio J; John T. Milliken Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
Arellano M; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
Blachly JS; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH.
Mannis GN; Division of Hematology, Stanford University School of Medicine, Stanford, CA.
Perl A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Dickens DS; University of Iowa Stead Family Children's Hospital, Iowa City, IA.
McMahon CM; UCHealth Blood Disorders and Cell Therapies Center, University of Colorado School of Medicine, Aurora, CO.
Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, and Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
Grove CS; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.
Stone R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Shami PJ; University of Utah Huntsman Cancer Institute, Salt Lake City, UT.
Mantzaris I; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY.
Greenwood M; Department of Haematology, Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia.
Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Cuglievan B; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kovacsovics T; City of Hope Phoenix, Goodyear, AZ.
Gu Y; Syndax Pharmaceuticals, Inc, Waltham, MA.
Bagley RG; Syndax Pharmaceuticals, Inc, Waltham, MA.
Madigan K; Syndax Pharmaceuticals, Inc, Waltham, MA.
Chudnovsky Y; Syndax Pharmaceuticals, Inc, Waltham, MA.
Nguyen HV; Syndax Pharmaceuticals, Inc, Waltham, MA.
McNeer N; Syndax Pharmaceuticals, Inc, Waltham, MA.
Stein EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

J Clin Oncol ; : JCO2400826, 2024 Aug 09.

Article em En | MEDLINE | ID: mdl-39121437

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google